ABOS
|
Acumen Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
ALZN
|
Alzamend Neuro, Inc.
|
US
|
NASDAQ
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
BCLI
|
Brainstorm Cell Therapeutics Inc.
|
US
|
NASDAQ
|
BHVN
|
Biohaven Pharmaceutical Holding Company Ltd.
|
US
|
NYSE
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
MITO
|
Stealth BioTherapeutics Corp.
|
US
|
NASDAQ
|
NRBO
|
NeuroBo Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
NRSN
|
NeuroSense Therapeutics Ltd.
|
US
|
NASDAQ
|
PMN
|
ProMIS Neurosciences Inc.
|
US
|
NASDAQ
|
SNPX
|
Synaptogenix, Inc.
|
US
|
NASDAQ
|
VCNX
|
Vaccinex, Inc.
|
US
|
NASDAQ
|
VIGL
|
Vigil Neuroscience, Inc.
|
US
|
NASDAQ
|
CGNSF
|
Cognetivity Neurosciences Ltd
|
US
|
OTC
|
ERGO
|
Entia Biosciences, Inc
|
US
|
OTC
|
GEBHF
|
Genting Berhad
|
US
|
OTC
|
GEBHY
|
Genting Berhad Spons
|
US
|
OTC
|